Magle Chemoswed: Initiates post-market study with SmartPAN - Redeye

Redeye leaves a comment following Magle’s announcement of a randomized controlled multicenter trial with leading European university hospitals to explore the efficacy of SmartPAN. We believe that positive results could accelerate uptake in key European markets and provide a foundation for future regulatory submissions, potentially including an entry into the US market.

Länk till analysen i sin helhet: https://www.redeye.se/research/1089140/magle-chemoswed-initiates-post-market-study-with-smartpan?utm_source=finwire&utm_medium=RSS